Physician profile
Dean Wang
NPI 1235438482
$78,904.63
in general payments reported to CMS, 2019-2025
18 companies · $13K in 2025
The $13K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,206 · 2021: $15K · 2022: $19K · 2023: $16K · 2024: $4,266 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $5,582 · Education: $5,057 · Food and Beverage: $3,656 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,575 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,159.40 |
| Travel and Lodging | $5,581.54 |
| Education | $5,056.94 |
| Food and Beverage | $3,655.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,575.00 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $26,261.77 | 2020-2023 | Rigidloop, Speedtrap, Truespan Orthocord |
| Vericel Corporation | $9,066.29 | 2019-2025 | Maci |
| Depuy Synthes Products, INC. | $8,504.90 | 2021 | |
| Ipsen Bioscience INC. | $8,400.00 | 2019 | |
| Arthrex, INC. | $7,012.10 | 2019-2025 | |
| Ranfac Corporation | $5,056.94 | 2025 | |
| Stryker Corporation | $4,002.00 | 2019-2025 | Insignia, Procinch, Iconix |
| Depuy Synthes Sales INC. | $3,605.46 | 2019-2025 | Milagro, Truespan Orthocord, Fms Duo |
| Moximed, INC | $2,890.15 | 2025 | Misha Knee System, Small, Left |
| Saxum Surgical, INC. | $1,624.11 | 2022-2024 | |
| Micromed INC | $1,317.73 | 2021-2022 | |
| Overture Orthopaedics | $526.24 | 2025 | Overtureti |
| Team_makena_llc | $262.01 | 2019-2021 | |
| Medacta USA, INC. | $124.01 | 2021 | |
| Linvatec Corporation | $101.29 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $51.89 | 2025 | Duallink, Graftlink, Graftlink Ts |
| Djo, LLC | $51.25 | 2021 | |
| Pacira Therapeutics, INC. | $46.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,392.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.